NASDAQ:ILMN Illumina (ILMN) Stock Price, News & Analysis $135.18 -3.84 (-2.76%) (As of 02:57 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Illumina Stock (NASDAQ:ILMN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Key Stats Today's Range$134.83▼$139.1350-Day Range$115.47▼$139.0252-Week Range$89.00▼$148.19Volume805,324 shsAverage Volume2.01 million shsMarket Capitalization$21.53 billionP/E RatioN/ADividend YieldN/APrice Target$152.05Consensus RatingModerate Buy Company OverviewIllumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.Read More… Only 1% of people know about these Hotspot Dates (Ad)Did you know almost every stock in the market has multiple “Hotspot Dates”? They indicate when the stock has gone up on the same dates… at the same time… FOR DECADES For example, have you ever traded a stock called Constellation Energy (ticker: CEG)? Maybe not… Energy stocks haven’t received much love over the past 12 months. But anybody who knew about the “Hotspot Date” during the last week in January…Go here to get Roger’s top FIVE Hotspot Stocks for This Month! Illumina Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks90th Percentile Overall ScoreILMN MarketRank™: Illumina scored higher than 90% of companies evaluated by MarketBeat, and ranked 210th out of 995 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingIllumina has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 12 buy ratings, 9 hold ratings, and 1 sell rating.Amount of Analyst CoverageIllumina has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Illumina's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth21.21% Earnings GrowthEarnings for Illumina are expected to grow by 21.21% in the coming year, from $3.63 to $4.40 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Illumina is -16.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Illumina is -16.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIllumina has a P/B Ratio of 3.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Illumina's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.06% of the outstanding shares of Illumina have been sold short.Short Interest Ratio / Days to CoverIllumina has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Illumina has recently increased by 9.17%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIllumina does not currently pay a dividend.Dividend GrowthIllumina does not have a long track record of dividend growth. Sustainability and ESG4.2 / 5Environmental Score-1.11 Percentage of Shares Shorted3.06% of the outstanding shares of Illumina have been sold short.Short Interest Ratio / Days to CoverIllumina has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Illumina has recently increased by 9.17%, indicating that investor sentiment is decreasing significantly. News and Social Media2.2 / 5News Sentiment0.97 News SentimentIllumina has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Illumina this week, compared to 14 articles on an average week.Search InterestOnly 25 people have searched for ILMN on MarketBeat in the last 30 days. This is a decrease of -22% compared to the previous 30 days.MarketBeat FollowsOnly 7 people have added Illumina to their MarketBeat watchlist in the last 30 days. This is a decrease of -42% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Illumina insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.17% of the stock of Illumina is held by insiders.Percentage Held by Institutions89.42% of the stock of Illumina is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Illumina's insider trading history. ILMN Stock News HeadlinesIllumina Inc (ILMN) Trading 5.9% Higher on Oct 2October 2 at 12:08 PM | gurufocus.comIllumina, Inc. (ILMN): A Bull Case TheoryOctober 2 at 10:57 AM | msn.comMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.October 3, 2024 | Paradigm Press (Ad)Illumina Inc. stock rises Monday, still underperforms marketOctober 1 at 5:06 AM | marketwatch.comShareholders in Illumina (NASDAQ:ILMN) are in the red if they invested three years agoOctober 1 at 5:06 AM | finance.yahoo.comIllumina, Inc. (NASDAQ:ILMN) Short Interest UpdateOctober 1 at 2:41 AM | americanbankingnews.comGRAIL: Post-Spinoff, Illumina Maintains Control And Incentive To Support SuccessSeptember 24, 2024 | seekingalpha.com3 Genomics Stocks Transforming HealthcareSeptember 19, 2024 | stocknews.comSee More Headlines ILMN Stock Analysis - Frequently Asked Questions How have ILMN shares performed this year? Illumina's stock was trading at $139.24 at the beginning of the year. Since then, ILMN stock has decreased by 2.2% and is now trading at $136.15. View the best growth stocks for 2024 here. How were Illumina's earnings last quarter? Illumina, Inc. (NASDAQ:ILMN) released its quarterly earnings results on Tuesday, August, 6th. The life sciences company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.24. The business's revenue was down 5.4% on a year-over-year basis. Does Illumina have any subsidiaries? Illumina subsidiaries include these companies: Grail, Enancio, BlueBee, Edico Genome, Conexio Genomics, GenoLogics, NextBio, and others. Who are Illumina's major shareholders? Top institutional shareholders of Illumina include Weybosset Research & Management LLC (0.01%) and Massmutual Trust Co. FSB ADV. Insiders that own company stock include Susan H Tousi, Jacob Thaysen, Aimee L Hoyt, Charles Dadswell, Phillip G Febbo and Alexander Aravanis. View institutional ownership trends. How do I buy shares of Illumina? Shares of ILMN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Illumina own? Based on aggregate information from My MarketBeat watchlists, some other companies that Illumina investors own include NVIDIA (NVDA), Alibaba Group (BABA), Tesla (TSLA), Netflix (NFLX), Walt Disney (DIS), PayPal (PYPL) and Salesforce (CRM). Company Calendar Last Earnings8/06/2024Today10/03/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:ILMN CUSIP45232710 CIK1110803 Webwww.illumina.com Phone(858) 202-4500Fax858-202-4766Employees9,300Year Founded1998Price Target and Rating Average Stock Price Target$152.05 High Stock Price Target$242.00 Low Stock Price Target$100.00 Potential Upside/Downside+10.4%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage23 Analysts Profitability EPS (Most Recent Fiscal Year)($8.15) Trailing P/E RatioN/A Forward P/E Ratio37.93 P/E GrowthN/ANet Income$-1,161,000,000.00 Net Margins-68.73% Pretax Margin-68.53% Return on Equity3.08% Return on Assets1.60% Debt Debt-to-Equity Ratio1.04 Current Ratio1.11 Quick Ratio0.86 Sales & Book Value Annual Sales$4.43 billion Price / Sales4.95 Cash Flow$3.79 per share Price / Cash Flow36.31 Book Value$36.18 per share Price / Book3.81Miscellaneous Outstanding Shares159,300,000Free Float159,029,000Market Cap$21.93 billion OptionableOptionable Beta1.15 Social Links This page (NASDAQ:ILMN) was last updated on 10/3/2024 by MarketBeat.com Staff From Our PartnersKamala’s tax plan is worse than you think—find out whyBuffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredIs Your 401(k) Kamala-Proof? 5 Critical Moves Before It's Too LateSecure Your Savings from a Kamala Presidency BEFORE the Election Your retirement savings are standing on a ...American Hartford Gold Group | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.